留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

环状RNA在系统性红斑狼疮中的潜在应用研究进展

李力 张瑞仙

李力, 张瑞仙. 环状RNA在系统性红斑狼疮中的潜在应用研究进展[J]. 昆明医科大学学报, 2024, 45(6): 161-165. doi: 10.12259/j.issn.2095-610X.S20240622
引用本文: 李力, 张瑞仙. 环状RNA在系统性红斑狼疮中的潜在应用研究进展[J]. 昆明医科大学学报, 2024, 45(6): 161-165. doi: 10.12259/j.issn.2095-610X.S20240622
Li LI, Ruixian ZHANG. Research Progress on The Potential Application of Circular RNA in Systemic Lupus Erythematosus[J]. Journal of Kunming Medical University, 2024, 45(6): 161-165. doi: 10.12259/j.issn.2095-610X.S20240622
Citation: Li LI, Ruixian ZHANG. Research Progress on The Potential Application of Circular RNA in Systemic Lupus Erythematosus[J]. Journal of Kunming Medical University, 2024, 45(6): 161-165. doi: 10.12259/j.issn.2095-610X.S20240622

环状RNA在系统性红斑狼疮中的潜在应用研究进展

doi: 10.12259/j.issn.2095-610X.S20240622
基金项目: 国家自然科学基金资助项目(82060305)
详细信息
    作者简介:

    李力(1998~),女,云南西双版纳人,在读硕士研究生,主要从事系统性红斑狼疮发病机制研究工作

    通讯作者:

    张瑞仙,E-mail:zhangrx2005@163.com

  • 中图分类号: R593.2

Research Progress on The Potential Application of Circular RNA in Systemic Lupus Erythematosus

  • 摘要: 环状RNA(circular RNA,circRNA)是由pre-mRNA反向剪接形成的1种闭合环状结构的RNA,其在分子特征、生物学功能和调控机制等方面均具有多样性。近年来,人们越来越认识到circRNA在多种人类疾病中发挥作用、并可能作为分子标志物用于预测疾病的诊断及预后,这其中包括经典的自身免疫性疾病——系统性红斑狼疮(systemic lupus erythematosus,SLE)。目前,已发现的部分circRNAs在SLE中表达失调,且可通过不同机制(如“分子海绵”作用、调节信号通路、抑制蛋白激酶激活和诱导细胞凋亡等)促进SLE的发生发展,另外一部分可作为SLE的潜在临床生物标志物,具有应用转化的潜能。就近年来有关circRNA在SLE中的研究展开综述,以期为circRNA在SLE中的后续研究提供科学依据和参考。
  • 图  1  环状RNA的形成及类型(本图通过Figdraw自绘)

    Figure  1.  Formation and types of circRNA(This figure is self-drawn via Figdraw)

  • [1] Dolgin E. Why rings of rna could be the next blockbuster drug[J]. Nature,2023,622(7981):22-24. doi: 10.1038/d41586-023-03058-7
    [2] Kristensen L S,Andersen M S,Stagsted L V W,et al. The biogenesis,biology and characterization of circular rnas[J]. Nat Rev Genet,2019,20(11):675-691. doi: 10.1038/s41576-019-0158-7
    [3] 娄雪,廖莉,赵若彤,等. 抗dsdna抗体、补体c3及其他实验室指标对于诊断系统性红斑狼疮肾损伤的临床意义[J]. 昆明医科大学学报,2021,42(2):49-53.
    [4] Lazar S,Kahlenberg J M. Systemic lupus erythematosus: New diagnostic and therapeutic approaches[J]. Annu Rev Med,2023,74(1):339-352. doi: 10.1146/annurev-med-043021-032611
    [5] Kour B,Gupta S,Singh R,et al. Interplay between circular rna,microrna,and human diseases[J]. Mol Genet Genomics,2022,297(2):277-286. doi: 10.1007/s00438-022-01856-8
    [6] Abbas A A,Abdulkader H A,Giordo R,et al. Implications and theragnostic potentials of circular rnas in rheumatic diseases[J]. Int J Biol Macromol,2023,235(12):123783.
    [7] Ji J,Zhang X,Ling Y,et al. Hsa_circ_0008301 as a potential biomarker of disease activity for primary sjogren's syndrome: Increased expression in peripheral blood of patients with primary sjogren's syndrome[J]. Int Immunopharmacol,2022,112(11):109231.
    [8] Chen L L. The biogenesis and emerging roles of circular rnas[J]. Nat Rev Mol Cell Biol,2016,17(4):205-211. doi: 10.1038/nrm.2015.32
    [9] Liu C X,Chen L L. Circular rnas: Characterization,cellular roles,and applications[J]. Cell,2022,185(12):2016-2034. doi: 10.1016/j.cell.2022.04.021
    [10] Chen X,Zhou M,Yant L,et al. Circular rna in disease: Basic properties and biomedical relevance[J]. Wiley Interdiscip Rev RNA,2022,13(6):e1723. doi: 10.1002/wrna.1723
    [11] Zhao X,Cai Y,Xu J. Circular rnas: Biogenesis,mechanism,and function in human cancers[J]. Int J Mol Sci,2019,20(16):3926. doi: 10.3390/ijms20163926
    [12] 吴亚彬,刘建华,秦晓松. 环状rna在自身免疫性疾病中的研究进展[J]. 中国免疫学杂志,2021,37(19):2416-2422.
    [13] Xu C,Zhang J. Mammalian circular rnas result largely from splicing errors[J]. Cell Rep,2021,36(4):109439. doi: 10.1016/j.celrep.2021.109439
    [14] Li K,Peng Z Y,Wang R,et al. Enhancement of tki sensitivity in lung adenocarcinoma through m6a-dependent translational repression of wnt signaling by circ-fbxw7[J]. Mol Cancer,2023,22(1):103. doi: 10.1186/s12943-023-01811-0
    [15] Conn V M,Gabryelska M,Toubia J,et al. Circular rnas drive oncogenic chromosomal translocations within the mll recombinome in leukemia[J]. Cancer Cell,2023,41(7):1309-1326. doi: 10.1016/j.ccell.2023.05.002
    [16] Zhou W Y,Cai Z R,Liu J,et al. Circular rna: Metabolism,functions and interactions with proteins[J]. Mol Cancer,2020,19(1):172. doi: 10.1186/s12943-020-01286-3
    [17] Du W W,Zhang C,Yang W,et al. Identifying and characterizing circrna-protein interaction[J]. Theranostics,2017,7(17):4183-4191. doi: 10.7150/thno.21299
    [18] Zheng F,Yu X,Tang D,et al. The identification of circular rnas from peripheral blood mononuclear cells in systemic lupus erythematosus[J]. BMC Med Genomics,2021,14(1):70. doi: 10.1186/s12920-021-00919-w
    [19] Luo Q,Ye Y,Zhang L,et al. Hsa_circ_0044235 and hsa_circ_0001947 as novel biomarkers in plasma of patients with new-onset systemic lupus erythematosus[J]. J Immunotoxicol,2023,20(1):2196453. doi: 10.1080/1547691X.2023.2196453
    [20] Luo Q,Li X,Fu B,et al. Expression profile and diagnostic value of circrnas in peripheral blood from patients with systemic lupus erythematosus[J]. Mol Med Rep,2021,23(1):1.
    [21] Zheng F,Tan L,Zhang F,et al. The circrna-mirna-mrna regulatory network in plasma and peripheral blood mononuclear cells and the potential associations with the pathogenesis of systemic lupus erythematosus[J]. Clin Rheumatol,2023,42(7):1885-1896. doi: 10.1007/s10067-023-06560-5
    [22] Lu H,Yang Y,Kuang D,et al. Expression profile of circrna in peripheral blood mononuclear cells of patients with rheumatoid arthritis[J]. BMC Med Genomics,2022,15(1):1-13. doi: 10.1186/s12920-021-01143-2
    [23] Doglio M,Alexander T,Del Papa N,et al. New insights in systemic lupus erythematosus: From regulatory T cells to car-t-cell strategies[J]. J Allergy Clin Immunol,2022,150(6):1289-1301. doi: 10.1016/j.jaci.2022.08.003
    [24] Zhao X,Dong R,Tang Z,et al. Circular rna circloc101928570 suppresses systemic lupus erythematosus progression by targeting the mir-150-5p/c-myb axis[J]. J Transl Med,2022,20(1):1-16. doi: 10.1186/s12967-021-03207-4
    [25] Luan J,Jiao C,Ma C,et al. Circmtnd5 participates in renal mitochondrial injury and fibrosis by sponging mir6812 in lupus nephritis[J]. Oxid Med Cell Longev,2022,2022(1):2769487.
    [26] Liu C X,Li X,Nan F,et al. Structure and degradation of circular rnas regulate pkr activation in innate immunity[J]. Cell,2019,177(4):865-880. doi: 10.1016/j.cell.2019.03.046
    [27] Mei H Y,Liu J,Shen X P,et al. A novel circrna,circracgap1,hampers the progression of systemic lupus erythematosus via mir-22-3p-mediated akt signalling[J]. Autoimmunity,2022,55(6):360-370. doi: 10.1080/08916934.2022.2073590
    [28] Guo P W,Huang H T,Ma J,et al. Circular rna-0007059 protects cell viability and reduces inflammation in a nephritis cell model by inhibiting microrna-1278/shp-1/stat3 signaling[J]. Mol Med,2021,27(1):372-376.
    [29] Zou H,Ma S,Li L,et al. Downregulation of circular rna ets1 promotes sle activity and inhibits treg cell differentiation through mir-1205/foxp3 molecular axis[J]. Int Immunopharmacol,2024,128(3):111539.
    [30] Wang Q,Xu B,Zhang Q,et al. The role of hsa_circ_0008945 in juvenile-onset systemic lupus erythematosus[J]. BMC Med Genomics,2023,16(1):97. doi: 10.1186/s12920-023-01524-9
    [31] Luo Q,Zhang L,Li X,et al. Identification of circular rnas hsa_circ_0044235 and hsa_circ_0068367 as novel biomarkers for systemic lupus erythematosus[J]. Int J Mol Med,2019,44(4):1462-1472.
    [32] Li W,Fan R,Zhou C,et al. Circular rna expression profile of systemic lupus erythematosus and its clinical significance as a potential novel biomarker[J]. Genes Genomics,2022,44(11):1405-1414. doi: 10.1007/s13258-022-01315-z
    [33] Li S,Zhang J,Tan X,et al. Microarray expression profile of circular rnas and mrnas in children with systemic lupus erythematosus[J]. Clin Rheumatol,2019,38(5):1339-1350. doi: 10.1007/s10067-018-4392-8
    [34] Li Y,Chen J,Xie M,et al. Identification of a circrna-mirna-mrna network to explore the effects of circrnas on renal injury in systemic lupus erythematosus[J]. Autoimmunity,2023,56(1):2193361. doi: 10.1080/08916934.2023.2193361
  • [1] 杨曼, 赵兴安, 葛芸娜, 秦娟, 王玺雅, 陶四明.  基于综合生物信息分析鉴定心房颤动相关炎症基因及其与免疫细胞浸润的关联, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240303
    [2] 杨敏, 林琪琪, 刘丹丹, 周宏宇.  水仙环素的抗肿瘤活性及机制研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240222
    [3] 沈枫, 杨一帆, 白茹, 李姝, 刘爽, 徐健.  全身免疫炎症指数与系统性红斑狼疮患者疾病活动度的关联分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241007
    [4] 熊煜欣, 杨莹.  糖尿病肾小管病研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230920
    [5] 朱晓栋, 刘演龙, 周旭, 戴海龙, 尹小龙.  cMyBP-C在急性心肌梗死临床诊断中的价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230328
    [6] 吴华杰, 屠德桢, 李磊, 乔涵, 李国萍.  白藜芦醇对鼻咽癌转移能力的影响及其分子机制, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230220
    [7] 李思琪, 邰文琳.  趋化因子CXCL10作为肝硬化生物标志物的意义, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220711
    [8] 马立花, 王湘宇, 杨一帆, 赵若彤, 丰晓妍, 徐健.  536例系统性红斑狼疮患者中性粒细胞/淋巴细胞比值与疾病活动度的关联性分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220209
    [9] 蔡金云, 王娟, 孙瑞希, 傅萍.  Rhupus综合征的临床特点, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210201
    [10] 娄雪, 廖莉, 赵若彤, 王湘宇, 杨一帆, 刘爽, 徐健.  抗dsDNA抗体、补体C3及其他实验室指标对于诊断系统性红斑狼疮肾损伤的临床意义, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210214
    [11] 廖莉, 娄雪, 赵若彤, 王湘宇, 杨一帆, 刘爽, 徐健.  中性粒细胞/淋巴细胞比值与系统性红斑狼疮患者肾脏损害的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210617
    [12] 李生浩, 李俊义, 武昆利, 徐晶晶, 常国楫, 王卫群, 张燕玲, 马志强, 王文林, 李树德.  龙胆苦苷的药理作用及分子机制研究进展, 昆明医科大学学报.
    [13] 刘桠名, 徐冕, 颜悦新, 周凤高, 许成, 赵琨, 蒋国云, 武彧, 刘荣.  基于代谢组学的脓毒症大鼠生物标志物研究, 昆明医科大学学报.
    [14] 陈怡.  雷公藤多甙联合醋酸泼尼松+硫酸羟基氯喹治疗系统性红斑狼疮, 昆明医科大学学报.
    [15] 袁杉.  抗C1q 抗体与系统性红斑狼疮及狼疮肾炎的相关性, 昆明医科大学学报.
    [16] 赵东岩.  TRFIA、FQ-PCR方法联合检测乙肝标志物的应用探讨, 昆明医科大学学报.
    [17] 李敬.  二维斑点追踪显像评价系统性红斑狼疮患者左心房功能, 昆明医科大学学报.
    [18] 杨小蕾.  系统性红斑狼疮患者STAT4基因mRNA和血清中IL-12、IFN-γ的表达, 昆明医科大学学报.
    [19] 芮桥安.  血清肿瘤标志物联检在结肠直肠癌诊断中的价值, 昆明医科大学学报.
    [20] 李绍祥.  RNA干扰的途径和机制, 昆明医科大学学报.
  • 加载中
图(1)
计量
  • 文章访问数:  591
  • HTML全文浏览量:  789
  • PDF下载量:  12
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-09-22
  • 网络出版日期:  2024-05-23
  • 刊出日期:  2024-06-25

目录

    /

    返回文章
    返回